JP2007519701A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007519701A5 JP2007519701A5 JP2006550323A JP2006550323A JP2007519701A5 JP 2007519701 A5 JP2007519701 A5 JP 2007519701A5 JP 2006550323 A JP2006550323 A JP 2006550323A JP 2006550323 A JP2006550323 A JP 2006550323A JP 2007519701 A5 JP2007519701 A5 JP 2007519701A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- butyl
- formula
- compound
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000003839 salts Chemical class 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 5
- 206010002091 Anaesthesia Diseases 0.000 claims 4
- 230000037005 anaesthesia Effects 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 238000011084 recovery Methods 0.000 claims 4
- 206010003591 Ataxia Diseases 0.000 claims 3
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical group O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 3
- 229920000858 Cyclodextrin Polymers 0.000 claims 2
- 239000003755 preservative agent Substances 0.000 claims 2
- 230000002335 preservative effect Effects 0.000 claims 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000002695 general anesthesia Methods 0.000 claims 1
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical group CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229940100630 metacresol Drugs 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229940097346 sulfobutylether-beta-cyclodextrin Drugs 0.000 claims 1
- 0 COc1c(CNC2C(C(c3ccccc3)c3ccccc3)N3CCC2CC3)cc(*)cc1 Chemical compound COc1c(CNC2C(C(c3ccccc3)c3ccccc3)N3CCC2CC3)cc(*)cc1 0.000 description 4
- NHZFXJIVSDECGN-NSOVKSMOSA-N COc(c(CN[C@@H]1[C@H](C(c2ccccc2)c2ccccc2)N2CCC1CC2)c1)ccc1Cl Chemical compound COc(c(CN[C@@H]1[C@H](C(c2ccccc2)c2ccccc2)N2CCC1CC2)c1)ccc1Cl NHZFXJIVSDECGN-NSOVKSMOSA-N 0.000 description 1
- OMBTXOIQSSBSPH-VMPREFPWSA-N Cc(cc1CN[C@@H]2[C@H](C(c3ccccc3)c3ccccc3)N3CCC2CC3)ccc1OC Chemical compound Cc(cc1CN[C@@H]2[C@H](C(c3ccccc3)c3ccccc3)N3CCC2CC3)ccc1OC OMBTXOIQSSBSPH-VMPREFPWSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54069704P | 2004-01-30 | 2004-01-30 | |
| PCT/IB2005/000010 WO2005082366A1 (en) | 2004-01-30 | 2005-01-06 | Nk-1 receptor antagonists anesthesia recovery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007519701A JP2007519701A (ja) | 2007-07-19 |
| JP2007519701A5 true JP2007519701A5 (enExample) | 2008-02-14 |
Family
ID=34910695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006550323A Withdrawn JP2007519701A (ja) | 2004-01-30 | 2005-01-06 | 麻酔回復を改善するためのｎｋ−１受容体拮抗剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20070155782A1 (enExample) |
| EP (1) | EP1713479A1 (enExample) |
| JP (1) | JP2007519701A (enExample) |
| KR (1) | KR100880391B1 (enExample) |
| CN (1) | CN1913893A (enExample) |
| AU (1) | AU2005216706B2 (enExample) |
| BR (1) | BRPI0507325A (enExample) |
| CA (1) | CA2554823A1 (enExample) |
| IL (1) | IL176830A0 (enExample) |
| MX (1) | MXPA06007964A (enExample) |
| NO (1) | NO20062965L (enExample) |
| RU (1) | RU2337685C2 (enExample) |
| WO (1) | WO2005082366A1 (enExample) |
| ZA (1) | ZA200605149B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1713504T1 (sl) | 2004-01-30 | 2017-10-30 | Zoetis Services Llc | Protimikrobni konzervansi za dosego večodmerne formulacije z uporabo beta-ciklodekstrinov za tekoče odmerne oblike |
| US9446029B2 (en) | 2010-07-27 | 2016-09-20 | Colorado State University Research Foundation | Use of NK-1 receptor antagonists in management of visceral pain |
| RU2489765C1 (ru) * | 2012-01-10 | 2013-08-10 | Открытое акционерное общество "Научно-исследовательский институт газоразрядных приборов "Плазма" (ОАО "Плазма") | Способ изготовления газонаполненного разрядника |
| CN114984223B (zh) * | 2022-05-31 | 2023-06-20 | 中国人民解放军陆军军医大学第二附属医院 | 生长激素促分泌素受体拮抗剂在制备吸入麻醉复苏制剂中的应用 |
| AT527172A1 (de) * | 2023-04-25 | 2024-11-15 | Vetviva Richter Gmbh | Maropitantformulierung |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US540897A (en) | 1895-06-11 | Harold f | ||
| US540644A (en) | 1895-06-11 | del yalle | ||
| SK278788B6 (sk) | 1991-05-31 | 1998-02-04 | Pfizer Inc. | Chinuklidínové deriváty, spôsob ich prípravy a pou |
| US5393762A (en) * | 1993-06-04 | 1995-02-28 | Pfizer Inc. | Pharmaceutical agents for treatment of emesis |
| US6255320B1 (en) * | 1999-06-01 | 2001-07-03 | Pfizer Inc. | Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions |
| WO2003009848A1 (en) * | 2001-07-20 | 2003-02-06 | Pfizer Products Inc. | Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses |
-
2005
- 2005-01-06 CN CNA2005800036680A patent/CN1913893A/zh active Pending
- 2005-01-06 BR BRPI0507325-1A patent/BRPI0507325A/pt not_active IP Right Cessation
- 2005-01-06 KR KR1020067015267A patent/KR100880391B1/ko not_active Expired - Fee Related
- 2005-01-06 EP EP05702181A patent/EP1713479A1/en not_active Withdrawn
- 2005-01-06 RU RU2006126828/15A patent/RU2337685C2/ru not_active IP Right Cessation
- 2005-01-06 CA CA002554823A patent/CA2554823A1/en not_active Abandoned
- 2005-01-06 JP JP2006550323A patent/JP2007519701A/ja not_active Withdrawn
- 2005-01-06 AU AU2005216706A patent/AU2005216706B2/en not_active Ceased
- 2005-01-06 WO PCT/IB2005/000010 patent/WO2005082366A1/en not_active Ceased
- 2005-01-06 MX MXPA06007964A patent/MXPA06007964A/es not_active Application Discontinuation
- 2005-01-06 US US10/587,590 patent/US20070155782A1/en not_active Abandoned
-
2006
- 2006-06-22 ZA ZA200605149A patent/ZA200605149B/en unknown
- 2006-06-26 NO NO20062965A patent/NO20062965L/no not_active Application Discontinuation
- 2006-07-13 IL IL176830A patent/IL176830A0/en unknown